CeasIng Cpap At standarD criteriA (CICADA): predicting a successful outcome

European Journal of Pediatrics
Yue YinDavid A Todd


This is a retrospective analysis of a multicentre randomised controlled trial (RCT) where we concluded that CeasIng Cpap At standerD criteriA (CICADA) in premature babies (PBs) <30 weeks gestational age (GA) was the significantly better method of ceasing CPAP. To identify factors that may influence the number of attempts to cease CPAP, we reviewed the records of 50 PBs from the RCT who used the CICADA method. PBs were grouped according to number of attempts to cease CPAP (fast group ≤2 attempts and slow group >2 attempts to cease CPAP). There were 26 (fast group) and 24 (slow group) PBs included in the analysis. Results showed significant differences in mean GA (27.8 ± 0.3 vs 26.9 ± 0.3 [weeks ± SE], p = 0.03) and birth weight ([Bwt]; 1080 ± 48.8 vs 899 ± 45.8 [grams ± SE], p = 0.01) between groups. Significantly fewer PBs in the fast group had a patent ductus arteriosus (PDA) compared to the slow group (5/26 (19.2%) vs 13/24 (54.2 %), p = 0.02). Bwt was a significant negative predictor of CPAP duration (r = -0.497, p = 0.03) and CPAP ceasing attempts (r = -0.290, p = 0.04). PBs with a higher GA and Bwt without a PDA ceased CPAP earlier using the CICADA method. Bwt was better than GA for predicting CPAP duration and attempts to...Continue Reading


Jun 17, 1971·The New England Journal of Medicine·G A GregoryW K Hamilton
Apr 1, 1982·American Journal of Diseases of Children·S C EngelkeL R Kuhns
Sep 1, 1996·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·H L Elliott
Nov 3, 1998·Archives of Disease in Childhood. Fetal and Neonatal Edition·P G DavisP Henschke
May 5, 2000·The Cochrane Database of Systematic Reviews·P G Davis, D J Henderson-Smart
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·A H Jobe, E Bancalari
Dec 5, 2002·Seminars in Neonatology : SN·Richard A Polin, Rakesh Sahni
Apr 30, 2003·Archives of Disease in Childhood. Fetal and Neonatal Edition·A G De PaoliP G Davis
Jun 14, 2003·The Cochrane Database of Systematic Reviews·P G Davis, D J Henderson-Smart
Jan 1, 2004·Neonatal Network : NN·Tami Irwin ShermanThomas H Shaffer
Nov 17, 2007·Archives of Disease in Childhood. Fetal and Neonatal Edition·A Greenough, M Prendergast
Feb 5, 2008·Pediatrics·William A Engle, American Academy of Pediatrics Committee on Fetus and Newborn
Feb 7, 2008·The Cochrane Database of Systematic Reviews·A G De PaoliC J Morley
Nov 4, 2008·The European Respiratory Journal·A Hackshaw
Aug 5, 2009·Pediatrics·Hany Aly
Oct 10, 2009·Pediatric Research·Praveen Ballabh
Apr 28, 2010·Pediatrics·Shannon E G Hamrick, Georg Hansmann
Dec 22, 2011·International Journal of Pediatrics·Shantanu RastogiJen-Tien Wung
May 9, 2014·Archives of Disease in Childhood. Fetal and Neonatal Edition·Margaret BroomDavid A Todd


Feb 24, 2017·Journal of Perinatology : Official Journal of the California Perinatal Association·S AmatyaShantanu Rastogi

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.